Patents by Inventor Geert Plaetinck

Geert Plaetinck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7943819
    Abstract: The present invention relates to control of pest infestation by inhibiting one or more biological functions. The invention provides methods and compositions for such control. By feeding one or more recombinant double stranded RNA molecules provided by the invention to the pest, a reduction in pest infestation is obtained through suppression of gene expression. The invention is also directed to methods for making transgenic plants that express the double stranded RNA molecules, and to particular combinations of transgenic pesticidal agents for use in protecting plants from pest infestation.
    Type: Grant
    Filed: September 15, 2006
    Date of Patent: May 17, 2011
    Assignee: Monsanto Technology LLC
    Inventors: James A. Baum, Claire A. Cajacob, Pascale Feldmann, Gregory R. Heck, Irene Nooren, Geert Plaetinck, Wendy Maddelein, Ty T. Vaughn
  • Publication number: 20090306189
    Abstract: The present invention relates to methods for controlling pest infestation using double stranded RNA molecules. The invention provides methods for producing transgenic cells expressing the double stranded RNA molecules, as well as compositions and commodity products containing or treated with such molecules.
    Type: Application
    Filed: September 18, 2006
    Publication date: December 10, 2009
    Inventors: Romaan Raemaekers, Pascale Feldmann, Geert Plaetinck, Irene Nooren, Els Van Bleu, Frederic Pecqueur, Laurent Kubler, Nicole Damme, Lies Degrave, Isabel Remory
  • Publication number: 20090300796
    Abstract: The present invention relates to methods for controlling pest infestation using double stranded RNA molecules. The invention provides methods for making transgenic plants that express the double stranded RNA molecules, as well as pesticidal agents and commodity products produced by the inventive plants.
    Type: Application
    Filed: September 18, 2006
    Publication date: December 3, 2009
    Inventors: Romaan Raemaekers, Pascale Feldmann, Irene Nooren, Geert Plaetinck, Frederic Pecqueur, Els Van bleu
  • Publication number: 20090263364
    Abstract: The present invention relates in generally to RNAi and its use in gene silencing. In particular, the present invention relates to methods and constructs for delivering double stranded RNA (dsRNA) to pest organisms.
    Type: Application
    Filed: October 25, 2005
    Publication date: October 22, 2009
    Applicant: Devgen NV
    Inventors: Thierry Andre Olivier Eddy Bogaert, Richard Zwaal, Geert Plaetinck, Jan Octaaf De Kerpel, Titus Jan Kaletta
  • Publication number: 20080241894
    Abstract: Improved vector constructs useful in the expression of double-stranded RNA are provided. The constructs are particularly useful for expression of double-stranded RNA in vitro and in vivo.
    Type: Application
    Filed: March 26, 2008
    Publication date: October 2, 2008
    Applicant: Devgen N.V.
    Inventors: Geert Plaetinck, Jean-Pierre Renard, Thierry Bogaert
  • Patent number: 7358069
    Abstract: Improved vector constructs useful in the expression of double-stranded RNA are provided. The constructs are particularly useful for expression of double-stranded RNA in vitro and in vivo.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: April 15, 2008
    Assignee: Devgen N.V.
    Inventors: Geert Plaetinck, Jean-pierre Renard, Thierry Bogaert
  • Publication number: 20070124836
    Abstract: The present invention relates to control of pest infestation by inhibiting one or more biological functions. The invention provides methods and compositions for such control. By feeding one or more recombinant double stranded RNA molecules provided by the invention to the pest, a reduction in pest infestation is obtained through suppression of gene expression. The invention is also directed to methods for making transgenic plants that express the double stranded RNA molecules, and to particular combinations of transgenic pesticidal agents for use in protecting plants from pest infestation.
    Type: Application
    Filed: September 15, 2006
    Publication date: May 31, 2007
    Inventors: James Baum, Claire Cajacob, Pascale Feldmann, Gregory Heck, Irene Nooren, Geert Plaetinck, Wendy Maddelein, Ty Vaughn
  • Patent number: 7005423
    Abstract: There is provided a method of identifying DNA responsible for conferring a particular phenotype in a cell which method comprises a) constructing a cDNA or genomic library of the DNA of the cell in a suitable vector in an orientation relative to a promoter(s) capable of initiating transcription of the cDNA or DNA to double stranded (ds) RNA upon binding of an appropriate transcription factor to the promoter(s), b) introducing said library into one or more of the cells comprising the transcription factor, and c) identifying and isolating a particular phenotype of the cell comprising the library and identifying the DNA or cDNA fragment from the library responsible for conferring the phenotype.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: February 28, 2006
    Assignee: Devgen NV
    Inventors: Geert Plaetinck, Christ Platteeuw, Katherine Mortier, Thierry Bogart
  • Publication number: 20040187170
    Abstract: There is provided a method of identifying DNA responsible for conferring a particular phenotype in a cell which method comprises a) constructing a cDNA or genomic library of the DNA of said cell in a suitable vector in an orientation relative to a promoter(s) capable of initiating transcription of said cDNA or DNA to double stranded (ds) RNA upon binding of an appropriate transcription factor to said promoter(s), b) introducing said library into one or more of said cells comprising said transcription factor, and c) identifying and isolating a particular phenotype of said cell comprising said library and identifying the DNA or cDNA fragment from said library responsible for conferring said phenotype.
    Type: Application
    Filed: April 16, 2004
    Publication date: September 23, 2004
    Applicant: Devgen NV
    Inventors: Geert Plaetinck, Christ Platteeuw, Katherine Mortier, Thierry Bogaert
  • Publication number: 20040166580
    Abstract: Improved vector constructs useful in the expression of double-stranded RNA are provided. The constructs are particularly useful for expression of double-stranded RNA in vitro and in vivo.
    Type: Application
    Filed: May 18, 2001
    Publication date: August 26, 2004
    Inventors: Geert Plaetinck, Jean-pierre Renard, Thierry Bogaert
  • Publication number: 20040133943
    Abstract: There is provided a method of identifying DNA responsible for conferring a particular phenotype in a cell which method comprises a) constructing a cDNA or genomic library of the DNA of said cell in a suitable vector in an orientation relative to a promoter(s) capable of initiating transcription of said cDNA or DNA to double stranded (ds) RNA upon binding of an appropriate transcription factor to said promoter(s), b) introducing said library into one or more of said cells comprising said transcription factor, and c) identifying and isolating a particular phenotype of said cell comprising said library and identifying the DNA or cDNA fragment from said library responsible for conferring said phenotype.
    Type: Application
    Filed: December 17, 2003
    Publication date: July 8, 2004
    Applicant: Devgen NV
    Inventors: Geert Plaetinck, Christ Platteeuw, Katharine Mortier, Thierry Bogaert
  • Publication number: 20030061626
    Abstract: There is provided a method of identifying DNA responsible for conferring a particular phenotype in a cell which method comprises a) constructing a cDNA or genomic library of the DNA of said cell in a suitable vector in an orientation relative to a promoter(s) capable of initiating transcription of said cDNA or DNA to double stranded (ds) RNA upon binding of an appropriate transcription factor to said promoter(s), b) introducing said library into one or more of said cells comprising said transcription factor, and c) identifying and isolating a particular phenotype of said cell comprising said library and identifying the DNA or cDNA fragment from said library responsible for conferring said phenotype.
    Type: Application
    Filed: January 25, 2002
    Publication date: March 27, 2003
    Inventors: Geert Plaetinck, Christ Platteeuw, Katherine Mortier, Thierry Bogaert
  • Patent number: 5712121
    Abstract: Chimeric polypeptides encoded by a DNA sequence having a first DNA subsequence coding for a fragment of at least one of the .alpha.-and/or .beta.-chain of the human interleukin-5 receptor, and a second DNA subsequence coding for the constant domains of a heavy--or a light-chain of a human immunoglobulin, or a fragment thereof are useful in treating illnesses with demonstrated eosinophilia.
    Type: Grant
    Filed: April 13, 1995
    Date of Patent: January 27, 1998
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Rene Devos, Walter Fiers, Jose van der Heyden, Geert Plaetinck, Jan Tavernier
  • Patent number: 5668256
    Abstract: Chimeric polypeptides encoded by a DNA sequence having a first DNA subsequence coding for a fragment of at least one of the .alpha.- and/or .beta.-chain of the human interleukin-5 receptor, and a second DNA subsequence coding for the constant domains of a heavy- or a light-chain of a human immunoglobulin, or a fragment thereof are useful in treating illnesses with demonstrated eosinophilia.
    Type: Grant
    Filed: April 13, 1995
    Date of Patent: September 16, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Rene Devos, Walter Fiers, Jose van der Heyden, Geert Plaetinck, Jan Tavernier
  • Patent number: 5455337
    Abstract: Chimeric polypeptides encoded by a DNA sequence having a first DNA subsequence coding for a fragment of at least one of the .alpha.- and/or .beta.-chain of the human interleukin-5 receptor, and a second DNA subsequence coding for the constant domains of a heavy- or a light-chain of a human immunoglobulin, or a fragment thereof are useful in treating illnesses with demonstrated eosinophilia.
    Type: Grant
    Filed: September 16, 1992
    Date of Patent: October 3, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Rene Devos, Walter Fiers, Jose van der Heyden, Geert Plaetinck, Jan Tavernier